Efectividad y seguridad de 2 dispositivos de fototerapia para el manejo humanizado de la ictericia

Woodgate, 2011, Neonatal jaundice, BMJ Clin Evid., 2011, 0319

Ostrow JD, Pascolo L, Brites D, Tiribelli C. Molecular basis of bilirubin-induced neurotoxicity. Trends Mol Med [Internet]. 2004 [consultado 12 Ago 2014];10:65–70. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/15102359

Mazeiras G, Rozé JC, Ancel PY, Caillaux G, Frondas-Chauty A, Denizot S, et al. Hyperbilirubinemia and neurodevelopmental outcome of very low birthweight infants: results from the LIFT cohort. PLoS One [Internet]. 2012 [consultado 11 Ago 2014];7:e30900. Disponible en: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3267748&tool=pmcentrez&rendertype=abstract

Maisels MJ, Watchko JF, Bhutani VK, Stevenson DK. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. J Perinatol [Internet]. 2012 [consultado 21 Jul 2014];32:660–4. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22678141

Vandborg PK, Hansen BM, Greisen G, Ebbesen F. Dose-response relationship of phototherapy for hyperbilirubinemia. Pediatrics [Internet]. 2012 [consultado 3 Ago 2014];130:e352–7. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22802603

Bhutani, 2011, Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation, Pediatrics., 128, e1046, 10.1542/peds.2011-1494

NICE. Neonatal jaundice. London: National Institute for Health and Clinical Excellence; 2010.

Morris BH, Tyson JE, Stevenson DK, Oh W, Phelps DL, O'Shea TM, et al. Efficacy of phototherapy devices and outcomes among extremely low birth weight infants: multi-center observational study. J Perinatol [Internet]. 2013 [consultado 13 Ago 2014];33:126–33. Disponible en: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3570170&tool=pmcentrez&rendertype=abstract

Szucs, 2013, Family-centered, evidence-based phototherapy delivery, Pediatrics., 131, e1982, 10.1542/peds.2012-3479

American Academy of Pediatrics. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics [Internet]. 2004;114:297–316. [Consultado Mar 3 2018]. Disponible en: http://www.citeulike.org/group/11862/article/5941222

Sachdeva, 2015, Intermittent versus continuous phototherapy for the treatment of neonatal non-hemolytic moderate hyperbilirubinemia in infants more than 34 weeks of gestational age: a randomized controlled trial, Eur J Pediatr., 174, 177, 10.1007/s00431-014-2373-8

Maisels, 2007, Randomized controlled trial of light-emitting diode phototherapy, J Perinatol., 27, 565, 10.1038/sj.jp.7211789

Vreman H.J. Functional Evaluation of the NeoMedLight Phototherapy Pad; 2008.

Neomedlight. BiliCocoon TM System. Villeurbanne, France: Neomedlight; 2015. p. 1–22.

Cortey, 2014, Efficacité des dispositifs médicaux de photothérapie dans le traitement de l’hyperbilirubinémie du nouveau-né, Le Cah Tech., 35, 105

Brown, 1985, Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia, Pediatrics., 75, 393, 10.1542/peds.75.2.393

Bhutani, 1999, Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns, Pediatrics., 103, 6, 10.1542/peds.103.1.6

Maisels, 2012, An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation, J Perinatol., 32, 660, 10.1038/jp.2012.71